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A simple, rapid, and precise high-performance thin-layer chromatographic (HPTLC) method for simultaneous estimation of two
antidiabetic drugs, metformin hydrochloride and sitagliptin phosphate, in tablet dosage form has been developed and validated.
Chromatography was performed on silica gel 60 F254 plates with butanol:water:glacial acetic acid (6:2:2, v/v/v) as mobile phase.
is system gave a good resolution for metformin hydrochloride (𝑅𝑅𝑓𝑓 value of 0.35 ± 0.01) and sitagliptin phosphate (𝑅𝑅𝑓𝑓 value of
0.75 ± 0.01). Detection and quanti�cation were carried out at 227nm. e linear regression data for the calibration plot showed
a good relationship with 𝑟𝑟 𝑟 𝑟𝑟𝑟𝑟𝑟5 and 0.9991 for metformin hydrochloride and sitagliptin phosphate, respectively. e method
was validated for precision and recovery. e limits of detection and quanti�cation were 13.05 and 39.56ng/𝜇𝜇L for metformin
hydrochlorideand2.65and8.03ng/𝜇𝜇Lforsitagliptinphosphate,respectively.eamountsofthedrugsinthemarketedformulation
were 99.86% and 98.91% for metformin hydrochloride and sitagliptin phosphate, respectively.
1. Introduction
Metformin hydrochloride (MET), N, N-dimethylimid-
odicarbonimidic diamide monohydrochloride (Figure 1(a)),
is an antihyperglycemic agent that improves glucose
toleranceinpatientwithtypeIIdiabetes,loweringbothbasal
and postprandial plasma glucose. Metformin hydrochloride
decreases hepatic glucose production, decreases intestinal
absorption of glucose, and improves insulin sensitivity
by increasing peripheral glucose uptake and utilization
[1]. Sitagliptin phosphate (SITA), (3R)-3-amino-1-[3-
(tri�uoromethyl)-6,8-dihydro-5h-[1,2,4]triazolo[3,4-
c]pyrazin-7-yl]-4-(2,4,5-tri�uorophenyl)butan-1-one
(Figure 1(b)), is new oral antidiabetic agent that blocks
dipeptidyl peptidase-4 (DPP-4) activity. SITA increased
incretin levels (GLP-1 and GIP) which inhibit glucagon
release, in turn decreases blood glucose, but more
signi�cantly increases insulin secretion; this suppresses
the release of glucagon from the pancreas and drives down
blood sugar levels [2].
A literature survey revealed that MET is oﬃcial in IP [4],
BP[3],andUSPNF[5],whileSITAisnotyetoﬃcialinanyof
the pharmacopoeia. A detailed literature survey found that
LC-MS/MS method has been reported for quantitation of
METandSITAfrommouseandhumandriedbloodspots[6].
UV spectrophotometry has also been used for simultaneous
determination of MET and SITA in tablet dosage form [7].
Determination of MET and SITA in tablet dosage form
by liquid chromatography has also been reported [8]. To
our knowledge, this is the �rst report of HPTLC method
for simultaneous estimation of MET and SITA in a tablet
dosage form. e HPTLC method is useful for simultaneous
processing of sample and standard, reduced need for internal
standard,loweranalysistimeandlesscostperanalysis,simple
sample preparation, no requirements of prior treatment for
solvents like �ltration and degassing, no interference from2 Journal of Chemistry
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F 1: Structural formula for MET (a) and SITA (b).
previous analysis, fresh stationary and mobile phases for
each analysis with no contamination, the ability for visual
detection with an open system, and to determine non-
UV absorbing compounds detected by postchromatographic
derivatization. It reveals that proposed method require less
time and less solvent for the analysis. So proposed method is
cost eﬀective as HPLC grade solvents are too costly.
2. Experimental
2.1. Materials. Butanol (AR grade) and glacial acetic acid
(AR grade) were supplied by SD Fine Chemicals (Mum-
bai, India). Distilled water was used throughout the study.
Reference standard of MET (99.5%) was procured from
Torrent Research Centre (Bhat, Gandhinagar, India). Ref-
erence standard of SITA (99.8%) was procured from MSD
Pharmaceuticals Private Limited (Bhiwandi, Maharashtra,
India).JANUMETtabletswerepurchasedfromlocalmarket.
2.2. HPTLC Instrumentation. A CAMAG HPTLC system
equipped with Linomat 5 autosampler, TLC scanner 3, and
winCATS 1.2.2 soware (CAMAG, Muttens, Switzerland)
was used. e slit dimension was kept at 5.00×0.45mm, and
20mm/sec scanning speed was employed. Chromatography
was performed on precoated silica gel 60 F254 TLC plates
(10 × 10cm, catalogue number 1.05554.007) (Merck, Darm-
stadt, Germany) using butanol:water:glacial acetic acid
(6:2:2, v/v/v) as mobile phase. e band length 6mm and
distance between bands 15mm were kept constant through-
out the study. Numbers of applications on the plates were
�ve for standards and three for test samples. e application
speed was 150nL/sec. Ascending development to a distance
of85mmwasperformedon20×10cmtwinthroughchamber
(CAMAG). Chromatograms were evaluated via peak area
aer scanning in absorbance mode at 227nm.
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F 3: Typical absorption spectra obtained from MET and SITA
drug solutions.
2.3. Preparation of Standard Solution. MET (100mg) and
SITA (10mg) reference substances were accurately weighed
and transferred to a 25mL volumetric �ask. e powder was
dissolved in and diluted to volume with methanol to furnish
concentrations of 4000𝜇𝜇g/mL MET and 400𝜇𝜇g/mL SITA.
is solution (2.5mL) was diluted to 10mL with methanol
to obtain a standard solution having a concentration of MET
(1000ng/𝜇𝜇L) and SITA (100ng/𝜇𝜇L).
2.4. Preparation of Sample Solution. Twenty tablets were
weighed and ground to a �ne powder. A quantity of powder
equivalent to 200mg MET and 20mg SITA was weighed
and transferred to a 50mL volumetric �ask. e powder was
dissolved in methanol, sonicated for 30min, diluted to vol-
ume upto mark to furnish a solution containing 4000𝜇𝜇g/mL
MET and 400𝜇𝜇g/mL SITA. e solution was �ltered through
�hatman�lterpapernumber41.en2.5mLofthesolution
was diluted to 10mL with methanol to furnish a solution
containing 1000ng/𝜇𝜇L MET and 100ng/𝜇𝜇L SITA.
2.5. Method Validation. Validation was done with respect to
various parameters required under ICH guideline Q2 (R1)
[9].Journal of Chemistry 3
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F 4: Chromatogram for standards of MET (6𝜇𝜇g/band) and
SITA (0.6𝜇𝜇g/band) (a) and JANUMET tablet (b).
T 1: Statistical evaluation of linear part of calibration depen-
dence of MET and SITA.
Parameter MET SITA
Range (ng/band) 500–10000 50–1000
Slope 3.3592 2.5678
Intercept +6273 +453
𝑟𝑟 0.9995 0.9991
2.5.1.Linearity. Calibrationcurvewasplottedoveraconcen-
tration range from 500 to 10000ng/band for MET and 50 to
1000ng/band for SITA. For the calibration curves, standard
solutionsofMETandSITA(0.5,2.0,4.0,6.0,8.0,and10.0𝜇𝜇L)
were applied to the plate. e plate was developed in a
developing chamber previously saturated with the mobile
phase for 15 minutes. Each reading was the average of three
determinations.
2.5.2. Accuracy (Percent of Recovery). e accuracy of the
method was determined by calculating recoveries of MET
and SITA by the standard addition method. e analyzed
samples (3000ng/band and 300ng/band) were spiked with
extra concentration levels of 1000, 3000, and 5000ng/band
for MET and 100, 300, and 500ng/band for SITA, and the
mixtureswerereanalyzedbytheproposedmethod.Recovery
analyses were repeated three times for each level of all
samples.
2.5.3. Precision. e precision of developed method was
checked by repeatedly (𝑛𝑛 𝑛 𝑛) injecting 6000ng/band sample
solution of MET and 600ng/band sample solution of SITA,
without changing the position of plate for HPTLC method.
Repeatabilityofasampleapplicationandmeasurementofthe
peak area were determined on the same day by the repeated
application (𝑛𝑛 𝑛 𝑛) of sample solutions, while intermediate
precision was evaluated by comparing the assays for three
diﬀerent days.
2.5.�. Limit of �etection and Limit of �uanti�cation. e
limit of detection (LOD) and limit of quanti�cation (LOQ)
were calculated using the equations LOD 𝑛 3.3 × 𝑁𝑁𝑁𝑁𝑁 and
LOQ 𝑛 10×𝑁𝑁𝑁𝑁𝑁, where 𝑁𝑁 is standard deviation of the peak
area (𝑛𝑛 𝑛 3), taken as measure of the noise, and 𝑁𝑁 is the slope
of the corresponding calibration curve.
2.5.5. Selectivity. Selectivity of the method was tested by
comparison of peaks of test compounds with those of
standards prepared as mentioned before.
2.6. Procedure for Assay. Twenty tablets were weighed and
powdered, and an amount of tablet powder equivalent to
200mg of MET and 20mg of SITA was taken in a 50mL
volumetric �ask, sonicated for 30min, and diluted to the
mark with methanol. e solution was �ltered through
Whatman paper number 41. en 2.5mL of the solution
was diluted to 10mL with methanol. 6𝜇𝜇L of this �ltrate
was applied to the HPTLC plate and developed, dried, and
scanned. Quantity analysis of MET and SITA was made on
the basis of peak areas received for standard solutions.
3. Resultsand Discussion
3.1. Wavelength Optimization. UV-vis spectra (Figure 2) of
MET and SITA were measured from 200 to 400nm and
227nm was used as the optimum wavelength throughout the
experiment for both substances.
3.2. Method Validation
3.2.1. Linearity. e calibration curve was linear from 500
to 10000ng/band for MET and from 50 to 1000ng/band for
SITA, respectively. Statistical evaluations of the linear part of
calibration dependence of MET and SITA are presented in
Table 1.
3.2.2. Accuracy (Percent of Recovery). e analyzed samples
were spiked with extra concentration levels of 1000, 3000,
and 5000ng/band for MET and 100, 300, and 500ng/band4 Journal of Chemistry
T 2: e recovery studies of MET and SITA.
Compound Amount taken
(ng)
Amount added
(ng)
Recovery (%) ± RSD (%)
(𝑛𝑛 𝑛 𝑛)
3000 1000 99.39 ± 1.10
MET 3000 3000 101.64 ± 1.01
3000 5000 98.14 ± 1.06
300 100 100.57 ± 0.73
SITA 300 300 99.29 ± 1.08
300 500 101.06 ± 0.71
T 3: Data indicating various validation parameters of HPTLC
method (𝑛𝑛 𝑛 𝑛).
MET SITA
Precision (𝑛𝑛 𝑛 𝑛)
Mean ± SD; RSD (%)
Method precision 99.86 ± 0.88; 0.88 98.91 ± 1.21; 1.23
Intraday precision 100.43 ± 0.49; 0.49 99.12 ± 0.71; 0.72
Interday precision 100.46 ± 1.14; 1.13 100.56 ± 1.43; 1.43
LOD (ng/𝜇𝜇L) 13.05 2.65
LOQ (ng/𝜇𝜇L) 39.56 8.03
for SITA, and the mixtures were reanalyzed by the proposed
method. Recovery analyses were repeated three times for
each level of all samples. e results are presented in Table 2.
3.2.3. Precision. e precision of the developed method
was expressed as a percentage of relative standard devia-
tion (percent of RSD) for repeatability (intraday precision)
and intermediate precision (interday precision). e data
obtained were within 2% RSD (Table 3).
3.2.4. �imit of Detection and �imit of Quanti�cation. e
LOD and LOQ values were 13.05 and 39.56ng/𝜇𝜇L for MET
and 2.65 and 8.03ng/𝜇𝜇L for SITA, respectively (Table 3). e
data showsthat themethod issensitive forthe determination
of MET and SITA.
3.2.5. Selectivity. Typical absorption spectra of MET and
SITA are shown in Figure 3. Selectivity of the method was
tested by comparison of peaks of test compounds with
those of standards prepared as mentioned before. Related
chromatogram is presented in Figure 3. us it can be
concludedthattheexcipientsdidnotinterferewiththepeaks
from standard drug solutions.
3.3. Application of the Validated Method to a Pharmaceutical
Preparation. e proposed validated method was success-
fully applied to determine MET and SITA in their combined
dosage form. e label claim was 500mg of MET and 15mg
of SITA per tablet. e percent of assay of MET and SITA
found in JANUMET tablets by the proposed method is
99.86% and 98.91%, with percent of RSD 0.88% and 1.23%,
respectively (Figure 4).
4. Conclusion
A new HPTLC method for simultaneous determination
of MET and SITA in pharmaceutical tablet formulation
has been developed. e method was found to be simple,
sensitive, precise, accurate, and speci�c for quanti�cation of
MET and SITA in pharmaceutical formulation. It does not
suﬀer from interference from common excipients present
in the pharmaceutical preparation and can be conveniently
adopted for quality-control analysis.
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